 |
|
|
| |
Efficacy and Safety of MK-5172 Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection: Final Results of the C-SPIRIT Study
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Edward Gane,1 Ziv Ben Ari,2 Lindsay Mollison,3 Eli Zuckerman,4 Rafael Bruck,5 Yaacov Baruch,6 Anita Howe,7 Janice Wahl,7 Sanhita Bhanja,7 Peggy Hwang,7 Yue Zhao,7 Michael N. Robertson7
1Auckland Clinical Studies, Grafton, Auckland, New Zealand; 2Liver Disease Center, Sheba Medical Center, Ramat Gan, Israel; 3Fremantle Hepatitis Services, Fremantle Hospital, Fremantle, Australia; 4Liver Unit, Carmel Medical Center Technion Faculty of Medicine, Haifa, Israel; 5Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 6Liver Unit, Rambam Health Care Campus, Haifa, Israel; 7Merck and Co., Inc. Whitehouse Station, NJ, USA
EASL:
|
| |
|
|
|
|
|
